Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Bilirubin Assay for Neonates Takes Only 60 Seconds

By LabMedica International staff writers
Posted on 14 Mar 2011
A neonatal total bilirubin assay requires only 100 µL of blood and offers test results in about 60 seconds.

The neonatal total bilirubin (nBili) test is performed on the RAPIDPoint 405 blood gas analyzer with software version 3.7. More...
With one small blood sample, a full range of analytes can be measured including bilirubin, blood gases, electrolytes, glucose, total hemoglobin, and other critical care parameters required to assess critically ill infants.

The RAPIDPoint 405 offers a no-maintenance, cartridge-based solution for critical care testing of whole blood--unlike the reagent-based chemistry analyzers that require the separation of plasma from the red blood cells prior to analysis. Ease of use, minimal sample size, and fast turnaround of test results enhance patient care.

Siemens (Erlangen, Germany) nBili test on the RAPIDPoint 405 Blood Gas Analyzer is intended to measure the concentration of bilirubin in an infant's blood as an aid for assessing the risk for kernicterus in a point-of-care setting.

Kernicterus is due to marked jaundice in the newborn period. The high blood level of the pigment bilirubin results in its deposition in the brain, which damages the brain. Today, no baby should develop brain damage from untreated jaundice. If a baby gets too jaundiced, the baby can be treated with phototherapy. The baby can be put under blue lights most of the day. If the baby gets very jaundiced, an exchange transfusion can be done. Kernicterus is also called bilirubin encephalopathy.

Related Links:

Siemens


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.